Previous close | 120.70 |
Open | 50.31 |
Bid | 113.75 |
Ask | 115.35 |
Strike | 175.00 |
Expiry date | 2022-09-16 |
Day's range | 120.70 - 120.70 |
Contract range | N/A |
Volume | |
Open interest | 3 |
Agios Pharmaceuticals' (AGIO) posts encouraging results for the second quarter. The company is enrolling participants across five pivotal studies evaluating the lead drug Pyrukynd.
Nektar (NKTR) reports dismal second-quarter 2022 results. The company's operating expenses increased due to restructuring expenses of $106.0 million incurred during the quarter.
Novavax (NVAX) closed the most recent trading day at $61.93, moving +1.34% from the previous trading session.